Myositis - 160 Studies Found
Completed |
: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis : Inclusion Body Myositis : 2009-05-11 |
Completed |
: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis : Inclusion Body Myositis : 2008-12-04 : Drug: Etanercept 50 milligrams subcutaneously every week |
Active, not recruiting |
: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 : Sporadic Inclusion Body Myositis : 2015-07-09 :
|
Completed |
: Blood-flow Restricted Exercise in Inclusion Body Myositis : Sporadic Inclusion Body Myositis : 2014-12-10 :
|
Active, not recruiting |
: Natalizumab in Inclusion Body Myositis (IBM) : Inclusion Body Myositis (IBM) : 2013-05-31 : Drug: Natalizumab Other Name: Tysabri |
Active, not recruiting |
: Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis :
: 2012-01-23 : Biological: rAAV1.CMV.huFollistatin344 |
Completed |
: Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients : Sporadic Inclusion Body Myositis : 2013-08-15 :
|
Active, not recruiting |
: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis : Inclusion Body Myositis (IBM) : 2015-05-13 :
|
Recruiting |
: Optimizing Treatment on Idiopathic Inflammatory Myopathies : Idiopathic Inflammatory Myopathies : 2017-03-09 : Drug: Intravenous Infusion Intravenous infusion of follow medicine at disease onset: methyprednisolone a |
Recruiting |
: A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy : Idiopathic Inflammatory Myopathy : 2009-09-03 |